Background: Early diagnosis of Alzheimer's disease (AD) and its onset in subjects affected by mild cognitive impairment (MCI) based on structural MRI features is one of the most important open issues in neuroimaging. Accordingly, a scientific challenge has been promoted, on the international Kaggle platform, to assess the performance of different classification methods for prediction of MCI and its conversion to AD. New method: This work presents a classification strategy based on Random Forest feature selection and Deep Neural Network classification using a mixed cohort including the four classes of classification problem, that is HC, AD, MCI and cMCI, to train the model. Moreover, we compare this approach with a novel classification strat...
BackgroundPredicting clinical course of cognitive decline can boost clinical trials' power and impro...
Alzheimer's disease is a brain disease that causes impaired cognitive abilities in memory, concentra...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects brain cells, and mild cognitive...
We built and validated a deep learning algorithm predicting the individual diagnosis of Alzheimer's ...
Some forms of mild cognitive impairment (MCI) are the clinical precursors of Alzheimer's disease (AD...
Some forms of mild cognitive impairment (MCI) are the clinical precursors of Alzheimer’s disease (AD...
There is a need for objective tools to help clinicians to diagnose Alzheimer's Disease (AD) early an...
This work validates the generalizability of MRI-based classification of Alzheimer's disease (AD) pat...
Alzheimer’s Disease (AD) represents the most frequent (60-80%) subtype of dementia and is one kind o...
Background: We present our results in the International challenge for automated prediction of MCI fr...
Abstract Background An increase in lifespan in our society is a double-edged sword that entails a gr...
Beyond detecting brain lesions or tumors, comparatively little success has been attained in identify...
Mild cognitive impairment (MCI) is a transitional stage between age-related cognitive decline and Al...
Alzheimer's disease (AD) is a progressive neurodegenerative condition marked by a decline in cogniti...
Mild Cognitive Impairment (MCI) is the stage between the declining of normal brain function and the ...
BackgroundPredicting clinical course of cognitive decline can boost clinical trials' power and impro...
Alzheimer's disease is a brain disease that causes impaired cognitive abilities in memory, concentra...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects brain cells, and mild cognitive...
We built and validated a deep learning algorithm predicting the individual diagnosis of Alzheimer's ...
Some forms of mild cognitive impairment (MCI) are the clinical precursors of Alzheimer's disease (AD...
Some forms of mild cognitive impairment (MCI) are the clinical precursors of Alzheimer’s disease (AD...
There is a need for objective tools to help clinicians to diagnose Alzheimer's Disease (AD) early an...
This work validates the generalizability of MRI-based classification of Alzheimer's disease (AD) pat...
Alzheimer’s Disease (AD) represents the most frequent (60-80%) subtype of dementia and is one kind o...
Background: We present our results in the International challenge for automated prediction of MCI fr...
Abstract Background An increase in lifespan in our society is a double-edged sword that entails a gr...
Beyond detecting brain lesions or tumors, comparatively little success has been attained in identify...
Mild cognitive impairment (MCI) is a transitional stage between age-related cognitive decline and Al...
Alzheimer's disease (AD) is a progressive neurodegenerative condition marked by a decline in cogniti...
Mild Cognitive Impairment (MCI) is the stage between the declining of normal brain function and the ...
BackgroundPredicting clinical course of cognitive decline can boost clinical trials' power and impro...
Alzheimer's disease is a brain disease that causes impaired cognitive abilities in memory, concentra...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects brain cells, and mild cognitive...